This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2025 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Uma Verma
Senior Director, Business Development and M&A at Biogen
Speaker

Profile

Uma Makhija Verma is Senior Director, Business Development and M&A at Biogen with a focus on rare neuromuscular and metabolic conditions.

Prior to Biogen, Uma held roles of increasing responsibility in business development at Otsuka Pharmaceuticals across pharma therapeutics and digital health, and held stints across consulting including at IMS Health and Ernst and Young.

Uma enjoys conceptualizing and executing win-win collaborations that bring innovative solutions to patients in areas of high unmet need. She Bachelor’s degree in Molecular Biology and Biochemistry from Hampshire College, Amherst, MA and earned a post-graduate degree in business from the Indian School of Business, India.

Agenda Sessions

  • Mergers & Acquisitions in Rare Disease – Balancing Growth with Preservation

    11:45am